Al Hammadi Holding Company

4007

SA13J051UJH4

Healthcare Facilities & Services

Delayed Saudi Arabian S.E. Other stock markets 14:22:51 18/01/2026 +03			5-day change	1st Jan Change
27.06 ^SAR	+1.27%		+0.30%	-3.29%

12-28	Al Hammadi Bags Antitrust Nod for Purchase of 40% Stake in Wareed Medical	MT
12-28	Al Hammadi gets Saudi GAC's NOC to acquire 40% of Wareed Medical Co	RE

Al Hammadi says Sudair Pharma applies for IPO on main market

Published on 12/07/2025 at 08:45 am +03

Reuters

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Al Hammadi Holding Company

12-28	Al Hammadi Bags Antitrust Nod for Purchase of 40% Stake in Wareed Medical	MT
12-28	Al Hammadi gets Saudi GAC's NOC to acquire 40% of Wareed Medical Co	RE
12-07	Al Hammadi's Sudair Pharmaceutical Co. Files IPO Application for Saudi Bourse Listing	MT
12-07	Al Hammadi says Sudair Pharma applies for IPO on main market	RE
12-03	HSBC Cuts Al Hammadi's PT, Keeps at Hold	MT
12-03	Al Hammadi to Buy 40% Stake in Wareed Medical	MT
12-03	Al Hammadi buys 40% of Wareed Medical Company	RE
11-13	Ubhar Capital Oman Reduces Al Hammadi's PT, Affirms Buy Rating	MT
11-10	Arqaam Capital Cuts Al Hammadi PT, Keeps Hold Rating	MT
11-09	Al Hammadi Posts Lower Q3 Net Profit; Revenue Inches Up	MT
11-09	Al Hammadi Q3 dividend per share SAR 0.20	RE
11-09	Al Hammadi announces dividends policy starting from Q3, 2025	RE
11-09	Al Hammadi Q3 profit SAR 51.89 million	RE
11-09	Al Hammadi Holding Announces its Dividends Distribution Policy Starting from Third Quarter of 2025	CI
11-09	Al Hammadi Holding Company announces Quarterly dividend, payable on November 27, 2025	CI
11-08	Al Hammadi Holding Company Reports Earnings Results for the Third Quarter Ended September 30, 2025	CI
27/10/25	Al Hammadi Further Extends MoU for Wareed Medical's Minority Stake Purchase	MT
23/10/25	Arqaam Capital Cuts Al Hammadi Holding PT, Keeps Hold Rating	MT
07/10/25	EFG-Hermes Brokerage Cuts Al Hammadi's PT, Affirms Buy Rating	MT
13/08/25	Ubhar Capital Oman Upgrades Al Hammadi to Buy	MT
11/08/25	Al Hammadi Holding Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
07/08/25	Al Hammadi Q2 dividend per share SAR 0.35	RE
07/08/25	Al Hammadi Q2 profit SAR 61.96 million	RE
07/08/25	Al Hammadi Posts Lower H1 Net Profit; Revenue Up	MT
07/08/25	Al Hammadi Holding Company announces Quarterly dividend, payable on August 21, 2025	CI

Chart Al Hammadi Holding Company

Duration

Period

4007: Dynamic Chart

Al Hammadi Holding Company SJSC is a Saudi Arabia-based company, which is engaged in management and operation of hospitals and medical centers, which provides healthcare services. The Company operates through two segments: Medical Services segment, which include fees for inpatient and outpatient services; and pharmaceutical products segment. The Company operates approximately two hospitals in the Saudi Arabian capital, housing approximately 600 inpatient rooms and 180 outpatient clinics. The Companyâs subsidiaries include Medical Support Services Company Limited, Pharmaceutical Services Company Limited, and Medical Industries Company Limited.

Employees

Sector

Healthcare Facilities & Services

Calendar

03-24 - Q4 2025 Earnings Release (Projected)

More about the company